AGP Executive Report
Last update: 8 hours agoDiabetes Tech & Care Access: A new ADA 2026 study found continuous glucose monitoring (CGM) can improve glucose control for adults with type 2 diabetes not using insulin, using the CONNECT trial to compare CGM vs routine fingerstick care. Obesity Drug Pipeline: Multiple ADA 2026 updates spotlight next-gen weight-loss options, including Novo Nordisk’s CagriSema (amylin + GLP-1) showing significant HbA1c and weight reductions, plus Boehringer/Zealand’s survodutide reporting weight and liver-fat benefits in phase 3 trials. Nursing Home Watch: CMS data for Q1 2026 show Heritage Manor South (Caddo) owned by ACT Investments/Medico with a 4-star overall rating, while Rosewood Nursing Center (Calcasieu) scored 2 with fines/penalties, and St. Bernard Nursing & Rehab (Orleans) scored 2. Public Health & Research Freedom: Police removed diabetes researchers from an ADA New Orleans conference after they distributed an editorial criticizing federal biomedical research cuts. Louisiana Safety Alerts: A Silver Alert was issued for a Port Allen man with a medical condition that may impair judgment; and Louisiana State Police reported a fatal UTV crash in Washington Parish where the driver was unrestrained. Community Health: Saints fans backed a St. Jude fundraiser in New Orleans with podcaster Tom Grossi.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.